Cargando…
Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer
Castration-resistant prostate cancer (CRPC) treatment still remains difficult. The aim of the present study was to determine the antitumour efficacy of the MutT homolog 1 (MTH1) inhibitor, TH1579, against castration-resistant prostate cancer. PC-3 and DU-145 prostate cancer cells were treated with d...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709546/ https://www.ncbi.nlm.nih.gov/pubmed/33281973 http://dx.doi.org/10.3892/ol.2020.12324 |